COVID-19 vaccine production is dramatically ramping up

This episode is brought to you by Semafor Healthcare.Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.According to survey company Civiqs, 51% of Americans plan on taking a COVID-19 vaccine if and when it becomes available. As the U.S. exceeds 500,000 deaths related to COVID-19, the Biden administration is working to deploy more than 200 million COVID-19 vaccine doses as well as combat vaccine hesitancy.On Health Affairs This Week, Leslie Erdelack and Chris Fleming discuss the latest on COVID-19, vaccine availability, and the status on various health policy court cases and administrative regulations.Related Links:COVID-19: U.S. Surpasses 500,000 COVID-19 Deaths, A Monumental Loss (New York Times)Hearing On "Pathway To Protection: Expanding Availability Of COVID-19 Vaccines" (House Committee on Energy & Commerce)Building On The Gains Of The ACA: Federal Proposals To Improve Coverage And Affordability (Health Affairs)As The Biden Administration Begins Unwinding Them, Medicaid Work Experiments Remain Unreasonable, Unnecessary, And Harmful (Health Affairs Blog)Ensuring Equitable Access To COVID-19 Vaccines In The US: Current System Challenges And Opportunities (Health Affairs)Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | OvercastMusic provided by Fake Fever. Subscribe to Semafor Healthcare for free.